Primecap Management CO Biogen Inc. Transaction History
Primecap Management CO
- $134 Billion
- Q3 2024
A detailed history of Primecap Management CO transactions in Biogen Inc. stock. As of the latest transaction made, Primecap Management CO holds 16,315,079 shares of BIIB stock, worth $2.55 Billion. This represents 2.37% of its overall portfolio holdings.
Number of Shares
16,315,079
Previous 16,338,294
0.14%
Holding current value
$2.55 Billion
Previous $3.79 Billion
16.5%
% of portfolio
2.37%
Previous 2.78%
Shares
29 transactions
Others Institutions Holding BIIB
# of Institutions
1,036Shares Held
126MCall Options Held
1.13MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.6 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.27 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.15 Billion0.06% of portfolio
-
Wellington Management Group LLP Boston, MA5.13MShares$800 Million0.18% of portfolio
-
Jpmorgan Chase & CO New York, NY5.1MShares$796 Million0.08% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $22.5B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...